TrialNature communications2025

Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.

Max Piffoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.